• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

NLRP3炎性小体作为炎症性疾病的治疗靶点

NLRP3 Inflammasome as Therapeutic Targets in Inflammatory Diseases.

作者信息

Prakash Annamneedi Venkata, Park Il-Ho, Park Jun Woo, Bae Jae Pil, Lee Geum Seon, Kang Tae Jin

机构信息

Department of Pharmacy and Institute of Chronic Disease, Sahmyook University, Seoul 01795, Republic of Korea.

Department of Counseling and Psychology, Sahmyook University, Seoul 01795, Republic of Korea.

出版信息

Biomol Ther (Seoul). 2023 Jul 1;31(4):395-401. doi: 10.4062/biomolther.2023.099.

DOI:10.4062/biomolther.2023.099
PMID:37376952
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10315342/
Abstract

Innate immunity is a first line defence system in the body which is for sensing signals of danger such as pathogenic microbes or host-derived signals of cellular stress. Pattern recognition receptors (PRR's), which present in the cell memebrane, are suspect the infection through pathogen-associated molecular patterns (PAMP), and activate innate immunity with response to promote inflammation via inflammatory cells such as macrophages and neutrophils, and cytokines. Inflammasome are protein complexes which are part of innate immunity in inflammation to remove pathogens and repair damaged tissues. What is the important role of inflammation in disease? In this review, we are focused on the action mechanism of NLRP3 inflammasome in inflammatory diseases such as asthma, atopic dermatitis, and sepsis.

摘要

固有免疫是机体的第一道防御系统,用于感知危险信号,如病原微生物或细胞应激的宿主来源信号。存在于细胞膜中的模式识别受体(PRR)通过病原体相关分子模式(PAMP)来怀疑感染,并通过巨噬细胞和中性粒细胞等炎症细胞以及细胞因子激活固有免疫以促进炎症反应。炎性小体是蛋白质复合物,是炎症中固有免疫的一部分,用于清除病原体和修复受损组织。炎症在疾病中起什么重要作用?在本综述中,我们重点关注NLRP3炎性小体在哮喘、特应性皮炎和脓毒症等炎症性疾病中的作用机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e6f/10315342/c9d58c78f4e9/bt-31-4-395-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e6f/10315342/ce8976c0a68d/bt-31-4-395-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e6f/10315342/75cd3725d6b4/bt-31-4-395-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e6f/10315342/c9d58c78f4e9/bt-31-4-395-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e6f/10315342/ce8976c0a68d/bt-31-4-395-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e6f/10315342/75cd3725d6b4/bt-31-4-395-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e6f/10315342/c9d58c78f4e9/bt-31-4-395-f3.jpg

相似文献

1
NLRP3 Inflammasome as Therapeutic Targets in Inflammatory Diseases.NLRP3炎性小体作为炎症性疾病的治疗靶点
Biomol Ther (Seoul). 2023 Jul 1;31(4):395-401. doi: 10.4062/biomolther.2023.099.
2
Therapeutic regulation of the NLRP3 inflammasome in chronic inflammatory diseases.NLRP3 炎性小体在慢性炎症性疾病中的治疗调控。
Arch Pharm Res. 2021 Jan;44(1):16-35. doi: 10.1007/s12272-021-01307-9. Epub 2021 Feb 3.
3
Extracellular acidosis is a novel danger signal alerting innate immunity via the NLRP3 inflammasome.细胞外酸中毒通过 NLRP3 炎性小体成为一种新的危险信号,激活先天免疫。
J Biol Chem. 2013 May 10;288(19):13410-9. doi: 10.1074/jbc.M112.426254. Epub 2013 Mar 25.
4
Specific NLRP3 inflammasome inhibitors: promising therapeutic agents for inflammatory diseases.特异性 NLRP3 炎性小体抑制剂:炎症性疾病的有前途的治疗药物。
Drug Discov Today. 2021 Jun;26(6):1394-1408. doi: 10.1016/j.drudis.2021.02.018. Epub 2021 Feb 23.
5
Regulation of the NLRP3 Inflammasome by Post-Translational Modifications and Small Molecules.NLRP3 炎性小体的翻译后修饰和小分子调节。
Front Immunol. 2021 Feb 2;11:618231. doi: 10.3389/fimmu.2020.618231. eCollection 2020.
6
LRRC8A is essential for hypotonicity-, but not for DAMP-induced NLRP3 inflammasome activation.LRRC8A 对于低渗诱导而非 DAMPs 诱导的 NLRP3 炎症小体激活是必需的。
Elife. 2020 Nov 20;9:e59704. doi: 10.7554/eLife.59704.
7
Host innate immune responses to sepsis.宿主对脓毒症的固有免疫反应。
Virulence. 2014 Jan 1;5(1):36-44. doi: 10.4161/viru.25436. Epub 2013 Jun 17.
8
Nuclear Receptors in the Control of the NLRP3 Inflammasome Pathway.核受体在 NLRP3 炎性小体通路调控中的作用。
Front Endocrinol (Lausanne). 2021 Feb 25;12:630536. doi: 10.3389/fendo.2021.630536. eCollection 2021.
9
The NLRP3 inflammasome regulates adipose tissue metabolism.NLRP3 炎性小体调节脂肪组织代谢。
Biochem J. 2020 Mar 27;477(6):1089-1107. doi: 10.1042/BCJ20190472.
10
Is the inflammasome a potential therapeutic target in renal disease?炎症小体是否是肾脏病治疗的潜在靶点?
BMC Nephrol. 2014 Jan 23;15:21. doi: 10.1186/1471-2369-15-21.

引用本文的文献

1
Atopic Dermatitis Management: from Conventional Therapies to Biomarker-Driven Treatment Approaches.特应性皮炎的管理:从传统疗法到生物标志物驱动的治疗方法。
Biomol Ther (Seoul). 2025 Sep 1;33(5):813-829. doi: 10.4062/biomolther.2025.081. Epub 2025 Aug 19.
2
Mitochondrial autophagy inhibits nucleotide-binding oligomerization domain-like receptor protein 3-mediated pyroptosis and alleviates endothelial cell injury in pregnancy-induced hypertension.线粒体自噬抑制核苷酸结合寡聚化结构域样受体蛋白3介导的细胞焦亡并减轻妊娠高血压综合征中的内皮细胞损伤。
Cytojournal. 2025 Jun 12;22:60. doi: 10.25259/Cytojournal_52_2025. eCollection 2025.
3

本文引用的文献

1
Atopic dermatitis-like skin lesions are suppressed in fat-1 transgenic mice through the inhibition of inflammasomes.脂肪 1 转基因小鼠通过抑制炎症小体抑制特应性皮炎样皮肤损伤。
Exp Mol Med. 2018 Jun 13;50(6):1-9. doi: 10.1038/s12276-018-0104-3.
2
Tranilast directly targets NLRP3 to treat inflammasome-driven diseases.曲尼司特通过靶向 NLRP3 治疗炎性小体驱动的疾病。
EMBO Mol Med. 2018 Apr;10(4). doi: 10.15252/emmm.201708689.
3
Der f1 induces pyroptosis in human bronchial epithelia via the NLRP3 inflammasome.f1 通过 NLRP3 炎性小体诱导人支气管上皮细胞发生细胞焦亡。
Nucleotide-Bound Oligomeric Domain-Like Receptor Protein 3 as a Serological Biomarker in Relation to Disease Severity and Delirium After Acute Pancreatitis: A Two-Center Prospective Cohort Study.
核苷酸结合寡聚结构域样受体蛋白3作为急性胰腺炎后疾病严重程度和谵妄相关的血清生物标志物:一项两中心前瞻性队列研究。
Int J Gen Med. 2025 Jun 26;18:3423-3440. doi: 10.2147/IJGM.S534284. eCollection 2025.
4
A phase 2a double-blind, placebo-controlled, randomized clinical trial evaluating the efficacy and safety of NuGel, a novel topical GPCR19-mediated inflammasome inhibitor, in patients with mild to moderate atopic dermatitis: a proof-of-concept study with biomarker analysis.一项2a期双盲、安慰剂对照、随机临床试验,评估新型局部GPCR19介导的炎性小体抑制剂NuGel在轻度至中度特应性皮炎患者中的疗效和安全性:一项带有生物标志物分析的概念验证研究。
Front Immunol. 2025 May 19;16:1560447. doi: 10.3389/fimmu.2025.1560447. eCollection 2025.
5
New Insights into AMPK, as a Potential Therapeutic Target in Metabolic Dysfunction-Associated Steatotic Liver Disease and Hepatic Fibrosis.AMPK作为代谢功能障碍相关脂肪性肝病和肝纤维化潜在治疗靶点的新见解
Biomol Ther (Seoul). 2025 Jan 1;33(1):18-38. doi: 10.4062/biomolther.2024.188. Epub 2024 Dec 20.
6
Chlorogenic acid alleviates IPEC-J2 pyroptosis induced by deoxynivalenol by inhibiting activation of the NF-κB/NLRP3/caspase-1 pathway.绿原酸通过抑制NF-κB/NLRP3/半胱天冬酶-1信号通路的激活来减轻脱氧雪腐镰刀菌烯醇诱导的IPEC-J2细胞焦亡。
J Anim Sci Biotechnol. 2024 Dec 2;15(1):159. doi: 10.1186/s40104-024-01119-z.
7
Marine Microorganism Molecules as Potential Anti-Inflammatory Therapeutics.海洋微生物分子作为潜在的抗炎治疗药物。
Mar Drugs. 2024 Sep 3;22(9):405. doi: 10.3390/md22090405.
8
Update on the pathogenesis of atopic dermatitis.特应性皮炎发病机制的研究进展。
An Bras Dermatol. 2024 Nov-Dec;99(6):895-915. doi: 10.1016/j.abd.2024.06.001. Epub 2024 Aug 12.
9
C-Reactive Protein Signaling Pathways in Tumor Progression.肿瘤进展中的C反应蛋白信号通路
Biomol Ther (Seoul). 2023 Sep 1;31(5):473-483. doi: 10.4062/biomolther.2023.132. Epub 2023 Aug 11.
Int J Mol Med. 2018 Feb;41(2):757-764. doi: 10.3892/ijmm.2017.3310. Epub 2017 Dec 5.
4
Mechanisms governing inflammasome activation, assembly and pyroptosis induction.调控炎症小体激活、组装和细胞焦亡诱导的机制。
Int Immunol. 2017 May 1;29(5):201-210. doi: 10.1093/intimm/dxx018.
5
Converging roles of caspases in inflammasome activation, cell death and innate immunity.半胱天冬酶在炎性小体激活、细胞死亡和固有免疫中的汇聚作用。
Nat Rev Immunol. 2016 Jan;16(1):7-21. doi: 10.1038/nri.2015.7. Epub 2015 Dec 14.
6
NLRP3 rs35829419 polymorphism is associated with increased susceptibility to multiple diseases in humans.NLRP3基因rs35829419多态性与人类对多种疾病易感性增加有关。
Genet Mol Res. 2015 Oct 30;14(4):13968-80. doi: 10.4238/2015.October.29.17.
7
NOD2 and TLR2 ligands trigger the activation of basophils and eosinophils by interacting with dermal fibroblasts in atopic dermatitis-like skin inflammation.在特应性皮炎样皮肤炎症中,NOD2和TLR2配体通过与真皮成纤维细胞相互作用触发嗜碱性粒细胞和嗜酸性粒细胞的活化。
Cell Mol Immunol. 2016 Jul;13(4):535-50. doi: 10.1038/cmi.2015.77. Epub 2015 Sep 21.
8
The Genetics and Epigenetics of Atopic Dermatitis-Filaggrin and Other Polymorphisms.特应性皮炎的遗传学与表观遗传学——丝聚合蛋白及其他多态性
Clin Rev Allergy Immunol. 2016 Dec;51(3):315-328. doi: 10.1007/s12016-015-8508-5.
9
Atopic dermatitis.特应性皮炎。
Lancet. 2016 Mar 12;387(10023):1109-1122. doi: 10.1016/S0140-6736(15)00149-X. Epub 2015 Sep 13.
10
Caspase-11 cleaves gasdermin D for non-canonical inflammasome signalling.半胱氨酸天冬氨酸蛋白酶 11 切割天冬氨酸半胱氨酸酶蛋白 D 以进行非经典炎性小体信号转导。
Nature. 2015 Oct 29;526(7575):666-71. doi: 10.1038/nature15541. Epub 2015 Sep 16.